Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

8-K Reg FD – X4 Pharmaceuticals, Inc (0001501697) March 21

Posted on March 21, 2023 By News Desk

Item 7.01Regulation FD DisclosureOn March 21, 2023, X4 Pharmaceuticals, Inc. (the “Company”) posted an updated corporate presentation on the Company’s website. To access the presentation, investors should visit the “Investors” section of the Company’s website at www.x4pharma.com.The information furnished under this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific re(…)

Full Original Filing »

SEC Filings

Post navigation

Previous Post: VERTEX ENERGY INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Vertex Energy Investors of a Class Action Lawsuit and Upcoming Deadline
Next Post: 8-K Other Events – Ellington Financial Inc. (0001411342) March 21

Archives

  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • Nubeva Successfully Decrypts Ransomware In Hospital Attack
  • Global Magnesium Oxide Market Sales to Reach US$ 16 Billion with likely to Grow at CAGR of 10% between 2023 to 2033 | Future Market Insights, Inc.
  • Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting
  • FuelCell Energy Reports Second Quarter of Fiscal 2023 Results
  • Watsco Joins the Prestigious Ranks of the Fortune 500

Copyright © 2023 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version